France: Medical and Donor Requirements in Surrogacy
France’s medical and gamete-donation rules cannot be used as a checklist for a domestic surrogacy programme. Article 16-7 of the French Civil Code says that any agreement concerning procreation or gestation for another person is null. That is the starting point even if intended parents propose to use their own gametes, donor sperm or eggs, an embryo, or have a medical reason that prevents pregnancy. The separate rules for assisted reproductive technology (ART, known in French as AMP) govern a regulated parental project; they do not create permission for one person to carry a child for someone else. The first question is therefore legal, not clinical: who is the treatment intended to help carry the pregnancy?
The legal starting point
Article 16-7 has been in force since 30 July 1994 and uses broad wording: “any agreement” concerning procreation or gestation for another is null. The text does not set out an exception for infertility, absence of a uterus, a medical contraindication to pregnancy, genetic risk, a donor-gamete arrangement, or an altruistic arrangement without payment. On the text of the provision, medical necessity or a particular choice of gametes does not by itself make a surrogacy agreement valid. This is a focused reading of the statutory wording, not a ruling on every possible fact pattern. Do not describe a medical indication as an exception unless a current, applicable legal authority has been identified and reviewed by French counsel.
This distinction should not be overstated. The rule does not mean that every fertility treatment or every use of donor gametes is prohibited in France, and this article does not make claims about criminal penalties. France has a separate regulated ART framework for eligible people pursuing their own parental project. If a woman receives IVF and will carry the resulting pregnancy herself, the ordinary ART rules may apply. If a clinic proposes embryo creation or transfer as part of an arrangement for another person to gestate and hand over the child, the ordinary ART rules do not remove the nullity of the agreement. A clinic’s advertising, laboratory capability, or donor availability is not legal authority for a surrogacy exception.
Ordinary ART is a separate route
Under Article L. 2141-2 of the Public Health Code, access to ordinary ART is available to a couple consisting of a man and a woman, a couple consisting of two women, or an unmarried woman, following the required consultations with the centre’s multidisciplinary clinical and biological team. The provision says access must not be differentiated on grounds such as marital status or sexual orientation. It is a rule for ART responding to a parental project, not a route for a male couple to arrange surrogacy in France. Eligibility under ordinary ART must be assessed on its own terms and should not be confused with legal permission to arrange gestation for another person.
Before ordinary ART is carried out, Article L. 2141-10 requires consultations with one or more doctors and other professionals from the centre’s multidisciplinary team. The team must check the applicant’s or couple’s motivation and medical situation, explain the chances of success or failure, side effects, short- and long-term risks, burdens and constraints, and provide the prescribed information guide. Consent is confirmed in writing after a one-month reflection period. Where treatment requires a third-party donor, the recipient couple or unmarried woman must also give consent before a notary under the applicable Civil Code rules. If a centre postpones or refuses ordinary ART, the reasons must be provided in writing when the applicants request them. These are ordinary ART safeguards, not a surrogacy approval process.
The age limits in Article R. 2141-38 concern specified ordinary ART procedures. In general, insemination, use of gametes or reproductive tissue, and embryo transfer may be carried out until the woman who is to carry the child reaches her 45th birthday; for the member of a couple who is not to carry the child, the limit is the 60th birthday. These are recipient-treatment limits, not donor-age limits and not a medical eligibility range for a surrogate. They do not create a way around Article 16-7. If a case is close to an age threshold, ask the authorised centre to confirm which procedure and date control before relying on a general summary.
Gamete donation: eligibility and safeguards
For ordinary gamete donation, Article L. 1244-2 requires the donor to be an adult; an emancipated minor cannot donate. The donor must first receive the legally required information, and consent to donation must be collected in writing. The donor may revoke that consent at any time until the gametes are used. The consent process is not just a signature: the medical team must explain the legal framework, implications for filiation, and the rules governing access to donor information. Under the current donor-information regime, a donor must expressly agree in advance to disclosure of their identity and non-identifying information to a donor-conceived person who requests access at adulthood; a person who refuses that consent cannot donate under that regime.
The official clinical good-practice rules for authorised ART centres set out additional donor eligibility criteria. The authorised centre’s team assesses clinical findings and whether the person’s circumstances are compatible with donation. The criteria are ages 18–37 inclusive for oocyte donors and 18–44 inclusive for sperm donors (before the 38th and 45th birthdays, respectively). These are criteria for donors in the regulated donation system, not age limits for intended parents or for a surrogate. Meeting an age criterion is not enough by itself: the centre must also assess medical history, the quality and suitability of the gametes, relevant risks, and whether the donation can be performed safely.
The Public Health Code requires a practitioner arranging a gamete donation to review the donor’s personal and family history and other relevant clinical information, and to order further investigations when needed. Testing must address the risk of transmitting infections covered by the applicable rules; sperm donation also requires microbiological examination. If a transmissible risk is identified and confirmed after any necessary further investigation or specialist advice, the donor must not be accepted. The official good-practice rules list screening for infections including HIV, hepatitis B and C, and syphilis, with other testing depending on the applicable rules and exposure. This is not a complete self-screening list: the centre must apply the rules in force when it conducts the donation.
The donor assessment also includes criteria specific to the type of gamete. For an oocyte donor, the team evaluates ovarian function, whether stimulation can be undertaken safely, and relevant risks such as venous or arterial thrombosis; the donor must be informed about stimulation, retrieval, risks and burdens. For a sperm donor, the rules require satisfactory sperm characteristics, including after preparation and freezing/thawing, satisfactory sperm culture, and testing for Chlamydia trachomatis and Neisseria gonorrhoeae. A documented family pedigree is reviewed for genetic risks, a karyotype is performed, and specialist or additional genetic assessment may be required where indicated. Genetic-risk investigations require the donor’s consent; a donor who refuses a required risk assessment cannot be retained. The authorised team makes the eligibility decision.
Donor-recipient confidentiality and the donor-conceived person’s access rights are different questions. In ordinary donation, the donor and recipient cannot learn each other’s identities. Under Civil Code Article 16-8, only the donor’s and recipient’s doctors may access identifying information where there is therapeutic necessity; this does not give either party a direct right to identify the other. Under the regime effective from 1 September 2022, a person conceived through ART with a third-party donor may, if they wish, request the donor’s identity and specified non-identifying information once they reach adulthood. The donor must have expressly consented to that disclosure before donation; otherwise the donation cannot proceed under that regime. Older stored gametes or donations made under previous rules may raise transitional questions, so the centre should confirm the applicable regime from the dates and records. The donation itself is not remunerated. Under Public Health Code Article L. 1211-4, the health establishment responsible for collection must fully cover the costs associated with it; this cost coverage is not remuneration to the donor. In addition, insemination with fresh donated sperm and mixing sperm are prohibited, and the use of one donor’s gametes must not deliberately result in more than ten children. These rules regulate ordinary donation and do not authorise surrogacy.
Decision matrix
| Issue | What the French rules establish | Practical meaning |
|---|---|---|
| Surrogacy agreement | Any agreement concerning procreation or gestation for another is null. | A medical indication or donor choice does not itself create an exception. |
| Ordinary ART | Access, clinical evaluation, consent and age limits apply to an eligible parental project. | These rules do not authorise gestation for another person. |
| Gamete donation | Donors undergo consent, medical and infection screening, and eligibility review. | These safeguards apply to regulated donation, not to a surrogacy agreement. |
| Donor information | Recipients and donors do not identify each other; only their doctors may access identifying information where therapeutically necessary; an adult donor-conceived person may request specified data. | Check the donation date and transition rules for older material. |
Practical steps before proceeding
- Ask who will carry the pregnancy and have the clinic describe the exact procedure and roles in writing.
- Ask which current legal provisions and clinical good-practice rules apply, and what authorisation the centre holds.
- Request the medical-screening, written donor-consent and traceability records that are relevant to the proposed ordinary ART procedure.
- If a French surrogacy programme is advertised, request the exact legal authority for the claimed exception; do not rely on marketing or “medical necessity”.
- If ordinary ART is refused or delayed, request written reasons and preserve contracts, invoices, messages, consent forms and medical records.
- Obtain independent advice from a French lawyer before signing, paying or taking further steps.
Cross-border limits
This article does not decide whether a surrogacy programme is lawful under another country’s law, or whether a foreign birth record, parentage decision, nationality claim or travel document will be recognised by France. The law of the place where treatment or gestation occurs and the French rules governing foreign parentage and civil-status documents are separate questions. Compliance with a foreign clinic’s donor-screening rules does not automatically settle the French legal consequences. For a cross-border plan, obtain advice in the relevant country and in France before embryo creation or transfer, and coordinate consent, donor-origin records and the documents that will be needed after birth. Parentage, registration, nationality and travel are outside this article’s detailed scope and require separate review.
Conclusion
The practical conclusion is narrow but important: French law provides detailed medical, consent, screening and donor-information rules for regulated ART and gamete donation, but those rules are not a medical exception to the nullity of a surrogacy agreement under Civil Code Article 16-7. First classify the proposed treatment by who will carry the pregnancy; then check the applicable ordinary ART and donation requirements with an authorised centre. If the proposal involves gestation for another person in France, do not treat donor availability, a medical indication or clinic policy as proof that the arrangement is legally valid. Have a French lawyer review the specific facts and current law before acting.
This material is general information, not legal advice.
Primary legal sources (official French texts)
The links below lead to French official legislation and binding clinical good-practice rules.
- Code civil, article 16-7
- Code civil, article 16-6
- Code de la santé publique, article L. 1211-4
- Code de la santé publique, article L. 2141-2
- Code de la santé publique, article L. 2141-10
- Code de la santé publique, article R. 2141-38
- Code de la santé publique, article L. 1244-2
- Code de la santé publique, article R. 1244-2
- Code de la santé publique, articles R. 1211-25 à R. 1211-28-1
- Code de la santé publique, article L. 2143-2
- Code de la santé publique, article L. 1244-3
- Code de la santé publique, article L. 1244-4
- Arrêté du 11 avril 2008 relatif aux règles de bonnes pratiques cliniques et biologiques d’AMP (version consolidée)
- Code civil, article 16-8
